Home > Healthcare > Pharmaceuticals > Drug Delivery > Autoinjectors Market

Autoinjectors Market Size

  • Report ID: GMI5412
  • Published Date: Mar 2023
  • Report Format: PDF

Autoinjectors Market Size

Autoinjectors Market size was valued at over USD 55 billion in 2022 and is projected to register over 13% CAGR between 2023 and 2032. Rising prevalence of chronic diseases, growing demand for self-injection devices, and advancements in technology are some of the factors contributing to global market growth.


Autoinjectors Market

To understand key trends  
Download Free Sample

The increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, and multiple sclerosis has also escalated the demand for autoinjectors. These conditions often require regular injections, and autoinjectors offer a safe and effective way to deliver these medications. According to the International Diabetes Federation (IDF), in 2021, approximately 537 million people worldwide had diabetes, and this number is expected to rise significantly in upcoming years. The IDF also estimated that nearly 50% of people with diabetes are undiagnosed, so the actual number of people living with diabetes may be higher than reported. Since, the majority are residing in low- and middle-income nations, and diabetes is directly responsible for 1.5 million annual deaths. Therefore, the growing importance of preventive care in developed and developing economies will spur autoinjectors market statistics.


An autoinjector is a medical device used for the administration of a specific dose of a medication, typically via injection. It is designed to be easy to use by the patient or caregiver and typically consists of a pre-filled syringe, a needle, and a spring-loaded mechanism that delivers the medication quickly and easily with the press of a button. Autoinjectors are commonly used to treat conditions such as allergies, arthritis, and multiple sclerosis, among others. They are often used in emergency situations where rapid administration of medication is necessary, and they can help reduce the risk of accidental needle stick injuries.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market share for autoinjectors was accounted at more than USD 55 billion in 2022 and is expected to record over 13% CAGR from 2023 to 2032.

Autoinjectors market share from the anaphylaxis therapy segment is forecasted to reach over USD 10 billion by end of 2032 owing to the rising prevalence and occurrence of anaphylaxis and food allergies.

Middle East & Africa autoinjectors industry is expected to reach over USD 12 billion by 2032 owing to the significant investments made in the development of new products by regional manufacturers.

AbbVie Inc., GlaxoSmithKline Plc., Mylan, Amgen, Becton, Ypsomed, Dickinson and Company, Eli Lilly and Company, Johnson & Johnson, and Antares Pharma, are some of the leading companies in the autoinjectors business.

Autoinjectors Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 230
  • Countries covered: 15
  • Pages: 175
 Download Free Sample